Mostafa Ali

2025 gross receipts of approximately $5.8MApproximately 32,000 prescriptions filled in 2025Serves a mix of Medicare, Medicaid, and commercial insurance patientsCurrently operates approximately 4–5 days per weekCurrent monthly rent is approximately $7000Experienced pharmacy staff currently in placeSeller is relocating out of the countryBuyer may have the opportunity to continue operating from the current location, subject to lease terms and applicable regulatory requirementsPotential for additional growth through expanded operating hours, increased staffing, higher prescription volume, and strengthened payer/physician relationshipsFinancial information and additional business details will be provided to qualified buyers following NDA execution and completion of preliminary due diligence. ... Less

Investment OpportunityEstablished, vertically integrated healthcare services platform specializing in Durable Medical Equipment (DME) and pharmacy operations, with a diversified recurring revenue model, strong reimbursement relationships, and scalable infrastructure.Over the past decade, the Company has built a significant multi-state presence, combining organic growth, operational sophistication, and defensible market positioning within essential healthcare services.Financial Highlights (FY2025)Revenue: $48.1M+Adjusted EBITDA: $19.3M+EBITDA Margin: 40%+Gross Margin: 72%+Diversified revenue streams across DME and pharmacy servicesBalanced mix of government and commercial payorsInvestment HighlightsMulti-State Platform with strong regional market shareRecurring and diversified reimbursement-driven revenueIntegrated operating infrastructure supporting scale and efficiencyStrategic healthcare referral relationshipsEstablished ... Less

Turnkey independent pharmacy with active license, major PBM contracts, and established insurance relationships in place. Includes Medicare Part B & D, Caremark, Express Scripts, Optum, Prime Therapeutics, Health Mart Atlas PSAO affiliation, and McKesson wholesaler relationship. Ideal for immediate market entry and scalable operations. ... Less